Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Friedrich Kueppers"'
Autor:
Friedrich Kueppers, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 1, Pp 58-61 (2024)
Externí odkaz:
https://doaj.org/article/55d1ecf15a7e425a9e904f18e7605084
Autor:
Farouk Dako, MD, MPH, Huaqing Zhao, PhD, Alexandra Mulvenna, BS, Yogesh Sean Gupta, DO, Scott Simpson, DO, Friedrich Kueppers, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 590-595 (2021)
Objective: To investigate the relationship between α1-antitrypsin deficiency (AATD), a disorder resulting in protease activity imbalances, and the risk of ascending aortic aneurysm. Methods: In this single-center study, from August 1, 2018, to Febru
Externí odkaz:
https://doaj.org/article/43efae3d63ce4946a395cbbdcc621165
Autor:
Friedrich Kueppers, Mark D. Andrake, Qifang Xu, Roland L. Dunbrack, Joannah Kim, Christopher L. Sanders
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-19 (2019)
Abstract Background Alpha 1 Antitrypsin (AAT) is a key serum proteinase inhibitor encoded by SERPINA1. Sequence variants of the gene can cause Alpha 1 Antitrypsin Deficiency (AATD), a condition associated with lung and liver disease. The majority of
Externí odkaz:
https://doaj.org/article/d32b605cb01a47899ade581892491c43
Autor:
Friedrich Kueppers
Publikováno v:
Respiratory Medicine Case Reports, Vol 32, Iss , Pp 101345- (2021)
Alpha 1 Antitrypsin Deficiency (AATD) is a rare condition primarily associated with lung complications and liver disease. As disease symptoms are similar to those in other respiratory conditions, patients generally experience long delays before recei
Externí odkaz:
https://doaj.org/article/284e407e4d094a9095d98ec386f30725
Autor:
Friedrich Kueppers, Farouk Dako, Yogesh Sean Gupta, Alexandra Mulvenna, Huaqing Zhao, Scott A. Simpson
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 590-595 (2021)
Objective To investigate the relationship between α1-antitrypsin deficiency (AATD), a disorder resulting in protease activity imbalances, and the risk of ascending aortic aneurysm. Methods In this single-center study, from August 1, 2018, to Februar
Autor:
Roland L. Dunbrack, Qifang Xu, Friedrich Kueppers, Mark Andrake, Joannah Kim, Christopher Sanders
Publikováno v:
BMC Medical Genetics, Vol 20, Iss 1, Pp 1-19 (2019)
BMC Medical Genetics
BMC Medical Genetics
Background Alpha 1 Antitrypsin (AAT) is a key serum proteinase inhibitor encoded by SERPINA1. Sequence variants of the gene can cause Alpha 1 Antitrypsin Deficiency (AATD), a condition associated with lung and liver disease. The majority of AATD case
Autor:
Friedrich Kueppers
Publikováno v:
COPD. 17(6)
Alpha 1 antitrypsin deficiency (AATD) is a rarely diagnosed hereditary condition characterized by low alpha 1 antitrypsin (AAT) levels, which can lead to early-onset emphysema due to accelerated degradation of lung tissue. Similar to C-reactive prote
Autor:
Friedrich Kueppers
Publikováno v:
Genetic Determinants of Pulmonary Disease ISBN: 9781003065029
Genetic Determinants of Pulmonary Disease
Genetic Determinants of Pulmonary Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63bdfe4a0eb92dd73ca45f7d5ae9c229
https://doi.org/10.1201/9781003065029-2
https://doi.org/10.1201/9781003065029-2
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 15:10-16
Alpha 1 Antitrypsin (AAT) is a highly polymorphic serum protein. Several genetic variants are associated with varying degrees of decreased serum levels; however, these levels can rise in response to infection, inflammation, injury and estrogen levels
Publikováno v:
Allergy and Asthma Proceedings. 38:108-114
BACKGROUND Alpha-1 antitrypsin deficiency (AATD) is a genetic condition characterized by low serum levels of the protein alpha-1 antitrypsin. Because there are no unique clinical symptoms that point to a definitive diagnosis of AATD, laboratory testi